CANbridge Pharmaceuticals Inc. (HKG:1228)
Hong Kong · Delayed Price · Currency is HKD 1.980
+0.030 (1.54%)
Jun 18, 2026, 3:25 PM HKT
CANbridge Pharmaceuticals Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 14.82 | -442.62 | -378.84 | -483.48 | -1,077 |
Depreciation & Amortization | 12.1 | 27.16 | 28.34 | 21.92 | 15.67 |
Other Amortization | 0.05 | 0.09 | 0.12 | 0.06 | 0.03 |
Loss (Gain) From Sale of Assets | -102.13 | -2.23 | 2.01 | 1.25 | -9.73 |
Asset Writedown & Restructuring Costs | 0.73 | 89.41 | 4.01 | - | - |
Stock-Based Compensation | 5.07 | 7.69 | 19.92 | 26.82 | 30.51 |
Other Operating Activities | -5.23 | 15.63 | 18.13 | 33.5 | 430.43 |
Change in Accounts Receivable | -13.35 | 14.64 | -12.17 | -9.91 | -2.1 |
Change in Inventory | 1.6 | 0.88 | 1.04 | 3.62 | -12.9 |
Change in Accounts Payable | 2.73 | 165.09 | 90.51 | 63.93 | -3.11 |
Change in Unearned Revenue | 46.39 | - | - | - | - |
Change in Other Net Operating Assets | -0.98 | 1.87 | -51.3 | 61.31 | 41.12 |
Operating Cash Flow | -38.21 | -122.4 | -278.23 | -280.98 | -587.07 |
Capital Expenditures | -0.01 | -0.11 | -5.14 | -15.2 | -5.09 |
Sale of Property, Plant & Equipment | 1.23 | 0.03 | - | - | - |
Sale (Purchase) of Intangibles | - | - | -35.33 | -0.14 | 131.18 |
Sale (Purchase) of Real Estate | - | 14.01 | 14.01 | - | - |
Other Investing Activities | - | - | -0.38 | -19.45 | - |
Investing Cash Flow | 1.23 | 13.93 | -26.86 | -34.79 | 126.09 |
Long-Term Debt Issued | 20.03 | 27.93 | 19.8 | 38.63 | 20.76 |
Long-Term Debt Repaid | -38.23 | -45.08 | -45.77 | -43.31 | -32.08 |
Net Debt Issued (Repaid) | -18.21 | -17.15 | -25.97 | -4.68 | -11.32 |
Issuance of Common Stock | 111.65 | 0.04 | 0.08 | 0.03 | 563.8 |
Other Financing Activities | -0.98 | -1.45 | -2.13 | -16.06 | -33.07 |
Financing Cash Flow | 92.47 | -18.57 | -28.02 | -20.7 | 854.31 |
Foreign Exchange Rate Adjustments | 0.64 | 0.05 | 6.85 | 41.81 | -8.32 |
Net Cash Flow | 56.12 | -126.99 | -326.26 | -294.66 | 385.01 |
Free Cash Flow | -38.22 | -122.5 | -283.38 | -296.18 | -592.16 |
Free Cash Flow Margin | -76.46% | -143.94% | -275.47% | -375.04% | -1900.31% |
Free Cash Flow Per Share | -0.08 | -0.29 | -0.67 | -0.70 | -6.28 |
Cash Interest Paid | 0.98 | 1.45 | 1.49 | 2.17 | 1.38 |
Levered Free Cash Flow | -58.45 | 16.48 | -202.09 | -142.04 | -207.98 |
Unlevered Free Cash Flow | -57.06 | 21.84 | -196.5 | -137.75 | -206.05 |
Change in Working Capital | 36.39 | 182.48 | 28.08 | 118.95 | 23.02 |